Peter J. Rix
Impact in
-
- Prostate Cancer Treatment and Research
- Advanced Breast Cancer Therapies
- Ophthalmology top 5%
- Glaucoma and retinal disorders
Papers in
-
- Inflammatory mediators and NSAID effects 2
- Genetics 6
- Estrogen and related hormone effects 6
- Co-authors
- Jeffrey H. Hager (3 shared papers)Dana E. Rathkopf (1 shared paper)Charles L. Sawyers (1 shared paper)Michael J. Morris (1 shared paper)Mithat Gönen (1 shared paper)Daniel Costin Danila (1 shared paper)Josef J. Fox (1 shared paper)Susan F. Slovin (1 shared paper)
- Journals
- Journal of Medicinal Chemistry (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Journal of Pharmaceutical Sciences (2 papers)Nature Communications (1 paper)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Peter J. Rix
24 papers receiving 1.8k citations
Peter J. Rix's Hit Papers
Peers
Comparison fields: 5 of 73
- Pulmonary and Respiratory Medicine 789
- Ophthalmology 147
- Genetics 301
- Pharmaceutical Science 64
- Organic Chemistry 233
Countries citing papers authored by Peter J. Rix
This map shows the geographic impact of Peter J. Rix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter J. Rix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter J. Rix more than expected).
Fields of papers citing papers by Peter J. Rix
This network shows the impact of papers produced by Peter J. Rix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter J. Rix. The network helps show where Peter J. Rix may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter J. Rix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ARN-509: A Novel Antiandrogen for Prostate Cancer Treatment Hit paper breakdown → | 2012 | 564 |
| 2 | 2015 | 222 | |
| 3 | 2013 | 218 | |
| 4 | 2001 | 189 | |
| 5 | 2016 | 111 | |
| 6 | 2018 | 65 | |
| 7 | 2009 | 62 | |
| 8 | 2010 | 55 | |
| 9 | 2010 | 54 | |
| 10 | 2017 | 50 | |
| 11 | 2014 | 45 | |
| 12 | 2015 | 41 | |
| 13 | 2018 | 33 | |
| 14 | 2007 | 32 | |
| 15 | 1997 | 28 | |
| 16 | 2008 | 27 | |
| 17 | 2022 | 20 | |
| 18 | 1996 | 17 | |
| 19 | 2010 | 13 | |
| 20 | 1998 | 12 |
About Peter J. Rix
Peter J. Rix is a scholar working on Pharmacology, Genetics, Physiology, Pharmaceutical Science and Pharmacology, having authored 24 papers that have together received 1.9k indexed citations. Recurring topics across this work include Estrogen and related hormone effects (6 papers), Synthesis and biological activity (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Pain Mechanisms and Treatments (3 papers), Inflammatory mediators and NSAID effects (2 papers), Pulmonary Hypertension Research and Treatments (2 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Hormonal and reproductive studies (2 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (789 citations), Ophthalmology (147 citations), Genetics (301 citations), Pharmaceutical Science (64 citations) and Organic Chemistry (233 citations). Peter J. Rix has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Jeffrey H. Hager, Dana E. Rathkopf, Charles L. Sawyers, Michael J. Morris, Mithat Gönen, Daniel Costin Danila, Josef J. Fox, Susan F. Slovin, Edna Chow Maneval and Martin Fleisher. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, Journal of Pharmaceutical Sciences and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.